English, Article edition: Cost Analysis of Amlodipine versus Enalapril in Patients with Coronary Artery Disease and Normal Blood Pressure: Findings from the CAMELOT Economic Substudy Joseph Menzin; Luke Boulanger; Simon Tang; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/106403
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost Analysis of Amlodipine versus Enalapril in Patients with Coronary Artery Disease and Normal Blood Pressure: Findings from the CAMELOT Economic Substudy
Author
  • Joseph Menzin
  • Luke Boulanger
  • Simon Tang
  • Kamlesh Thakker
  • Steven E. Nissen
Physical Description
  • article
Notes
  • Objectives To analyse 2-year hospitalization and cost data collected during a prospective, double-blind, randomized, controlled trial comparing amlodipine, enalapril and placebo in normotensive patients with coronary artery disease (CAD). Methods All patients who were enrolled in the CAMELOT study were included in this economic substudy. Patients with CAD and normal blood pressure were randomized to amlodipine, enalapril or placebo, and followed up for 24 months (between 1999 and 2004). Data on hospitalizations and medication use were obtained from the clinical trial. Costs were assigned from secondary sources. Total costs ($US, year 2004 values) were estimated as the sum of costs associated with cardiovascular hospitalizations, study medications and concomitant cardiovascular medications. Costs and resource use were analysed by treatment arm overall and for selected patient subgroups. Cost differences were evaluated using nonparametric bootstrap techniques. Results Of 1991 patients enrolled, 663 were treated with amlodipine, 673 were treated with enalapril and 655 were treated with placebo. Significantly fewer patients were hospitalized for cardiovascular reasons in the amlodipine group (16.4%) than in the placebo group (22.7%; p <0.01), but not compared with the enalapril group (20.1%; p-0.09). The amlodipine group also had numerically fewer days in hospital per patient (1.1) than the enalapril (1.3) and placebo (1.5) groups. Mean 2-year per-patient costs in the amlodipine group were estimated to be $US609 and $US717 lower than for the placebo and enalapril groups, respectively. Conclusions These results suggest that use of amlodipine may reduce costs of care among CAD patients with normal blood pressure.
  • RePEc:wkh:aheahp:v:6:y:2008:i:2-3:p:157-162
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment